Helen Blau

Last updated
Helen Blau
FRS
Helen Blau 2013 (cropped).jpg
Blau in 2013
Born
Helen Margaret Blau

London, England
Nationality
  • British
  • American
Other namesHelen M Blau
Alma mater
Spouse David Spiegel
Children2
Family Eve Blau (sister)
Scientific career
Fields Developmental biology, Regenerative medicine, Stem cell biology
Institutions Stanford University Medical School
Website Blau Lab website

Helen Blau FRS is a cell biologist and stem cell researcher famous for her work on muscle diseases, regeneration and aging. She is the Donald E. and Delia B. Baxter Foundation Professor and the Director of the Baxter Laboratory for Stem Cell Biology at Stanford University. [1] Blau is known for overturning the prevailing view that once a cell assumes a certain specialty in the body — or differentiated state —such as a skin or liver cell, it cannot be changed. Her research established that the fate of mammalian cells can be altered. [2] [3] [4] [5] Her finding that specialized cells can be triggered to turn on genetic programs characteristic of other differentiated states provided early evidence that mammalian cellular reprogramming was possible and opened the door to the use of reprogramming in stem cell biology. [6]   Her work set the stage for the development of induced pluripotent stem cells and associated stem cell therapies. [7]

Contents

Blau is also known internationally for her work on adult stem cells and how they maintain, repair and rejuvenate tissues, in particular muscle. [8] [9] [10] [11] [12]   She revealed the role of the microenvironment of the niche, most notably tissue stiffness, in regulating stem cell function and showed how stem cell function declines in aging and hereditary muscle wasting diseases. She discovered ways to rejuvenate aged stem cell function.  Blau discovered a new class of aging-associated enzyme she termed a “gerozyme” and showed that pharmacological targeting of the gerozyme in aged muscle tissue can rejuvenate tissue structure and metabolism and increase strength. [13] [14]

Education and early life

Blau was born in London and is a dual citizen of the United States and Great Britain. She earned a B.A. from the University of York in England and an M.A. and Ph.D. in biology from Harvard University with Fotis C. Kafatos.

Career and research

After a postdoctoral fellowship with Charles J. Epstein in the departments of Biochemistry and Biophysics and the Division of Medical Genetics at The University of California, San Francisco (UCSF), she joined the faculty at Stanford University in 1978. She was awarded an endowed chair in 1999 and named Director of the Baxter Laboratory for Stem Cell Biology in 2002. She is married to David Spiegel, also a Professor at Stanford. They have two children, Daniel Blau Spiegel and Julia Blau Spiegel.

Cellular reprogramming and plasticity

It was long thought that the differentiated state is fixed and irreversible. In the 1980s, Blau challenged that idea using a cell fusion system she devised to join cells of two different species and differentiated states.  Her experiments showed that previously silent genes could be activated. [2] [3] [4] [5] Specifically, when human skin, connective tissue, or liver cells were fused with mouse muscle cells, the human cells began to make muscle-specific gene products. This body of work showed that the differentiated state requires continuous reinforcement, and that a shift in the balance of regulator proteins called transcription factors in the nucleus can reprogram the cell to become a different type of cell. [6] [15] [16]   This discovery of an unexpected plasticity, or flexibility, in cell fate was foundational for the development of the field of stem cell biology and regenerative medicine.  It was featured as “Plasticity of the Differentiated State” on the cover of the Frontiers in Biology special issue of the journal Science in 1985. [17]

Muscle stem cell biology

Adult stem cells are found in tissues throughout the body. When they divide during development, or to repair damage after injury, one daughter cell remains a stem cell (it self-renews), while the other differentiates (it specializes) to become one of the cell types that make up that tissue.

In 2008, Blau published the first parameters for isolating muscle stem cells, also known as satellite cells, using flow cytometry. Her lab pioneered the use of bioluminescence imaging to monitor the dynamics of muscle stem cell engraftment in muscles in live mice and confirmed that the cells were true stem cells, capable of both self-renewal and differentiation. [8] They also designed a bioengineered hydrogel with a stiffness that mimics healthy young muscle. Unlike rigid plastic tissue culture dishes, the elastic hydrogel preserves the stemness of the cells when grown in culture. [9] [18] [19] This discovery provided the first functional link between substrate elasticity and the maintenance of stem cell self-renewal properties and established a paradigm with broad utility to enhance the regenerative capacity of tissue-specific stem cells grown in the laboratory.

Muscle regeneration after injury

In 2014 Blau’s lab provided early evidence that stem cell function declines during aging due to internal defects, in addition to external factors. [10] They identified a small molecule, SB202, that inhibits an enzyme associated with aging called p38-MAP kinase and showed that the regenerative properties of aged muscle stem cells could be rejuvenated through a combination of biophysical (growth on the bioengineered hydrogels Blau’s lab designed) and biochemical (blocking p38MAPK) signals. [20] More recently, Blau showed that muscle stem cells exhibit an age-dependent increase in CD47 levels, and that this increase is a hallmark of age-related muscle stem cell dysfunction. [12] CD47 is a protein found on the surface of many cells in the body that protects them from attack by the body’s immune system; an increase in the number of CD47 molecules on old or diseased cells can prevent the body from disposing of them properly. Overcoming this increase in CD47 levels led to a robust increase in muscle strength after injury. [12] These approaches provide a paradigm for cell therapy strategies to treat muscle wasting.

In 2017 Blau’s lab identified prostaglandin E2 (PGE2) as a critical component of the inflammatory response that orchestrates the natural muscle repair process.  They showed that blocking the ability of muscle stem cells to respond to PGE2, or treatment with non-steroidal anti-inflammatory drugs like ibuprofen that inhibit PGE2 synthesis, leads to loss of muscle strength after injury. [11] Injection of PGE2 into injured muscles causes resident muscle stem cells to increase in number and enhances muscle repair. [11] These experiments showed that PGE2 is required and sufficient for muscle stem cell function in recovery after injury.

Gerozymes

In 2021 Blau discovered that with aging muscles accumulate increasing amounts of the enzyme 15-PGDH, the prostaglandin degrading enzyme which breaks down PGE2. [13] This enzyme appears to be a master regulator of muscle aging.  If 15-PGDH is overexpressed in muscles of young mice, they exhibit muscle atrophy and weakness that mimic the effect of years of aging. Conversely, using a small molecule drug to reduce the activity of 15-PGDH in old mice markedly increases muscle mass, strength and endurance when running on a treadmill. [13] These experiments showed that 15-PDGH is a pivotal molecular determinant of aging in muscle — a new class of molecule Blau termed a “gerozyme”. [14]

When skeletal muscles lose synapses, points of contact with the nerves, they atrophy and weaken, which compromises mobility and affects quality of life. Denervation can be sudden due to a traumatic injury that compresses or severs the nerves or can occur progressively over time with disease or age.  A total of 3 to 5% of the population in the United States suffers from such disorders, and the available treatment options are limited. [21] [22]   Blau’s laboratory showed that inhibiting the gerozyme restores neuromuscular connections after either an acute or chronic loss of synapses due injury or aging. [14]

Further experiments showed that blocking the activity of the gerozyme has a synergistic beneficial effect on muscle: enhancing the number and function of cellular energy factories called mitochondria, remodeling the arrangement of protein filaments called myofibrils that make up muscle fibers, and repressing harmful aging-associated pathways. [13] Coupled with its effect on muscle stem cells and motor axons, 15-PGDH represents a potent target for treatments designed to enhance muscle strength in those who are frail due to muscle disuse, genetic disease, or age. Blau is actively involved in efforts to translate these findings to the clinic.

Innovation

Blau is an ardent inventor who holds 16 issued US patents and numerous international patents which focus on assays of protein interactions, methods for telomere extension and tissue regeneration. [23] She earned an Outstanding Inventor Award from the Stanford University Office of Technology Licensing and is recognized as one of Stanford’s top innovators. She was elected to the National Academy of Inventors in 2017. [24] Blau consults for biotechnology and pharmaceutical companies and is the founder of two companies focused on regenerative medicine to increase healthspan.

Teaching and Mentoring

Blau is known for her support of women in science and her success in mentoring numerous young scientists who comprise the next generation of academic leaders in muscle biology, stem cell biology and regenerative medicine.  She has trained more than 95 students and postdoctoral scholars and she mentors young scientists at all levels.

Other Activities

Blau has served on many prominent scientific advisory boards and councils, including the Harvard Board of Overseers, the National Academy of Sciences, the National Academy of Medicine, NIH National Institute on Aging, the American Academy of Arts and Sciences, the American Society for Cell Biology, American Society for Gene Therapy, Ellison Medical Foundation, and the International Society for Stem Cell Research. She has served as the president of the American Society for Developmental Biology and president of the International Society of Differentiation. She has organized numerous national and international conferences and is an elected member of the Pontifical Academy of Sciences that advises Pope Francis at the Vatican.

Blau is an active proponent of the ethical use of stem cells, fetal tissues and animals in research and she has contributed to multiple articles in the New England Journal of Medicine discussing animal research policies [25] and the use of human fetal tissue in medicine. [26] Recently, she helped implement the International Society for Stem Cell Research’s 2023 “Guidelines for Stem Cell Research and Clinical Translation”. [27]

Honors & Awards

Honors – elected member

Honorary Doctorates

Selected Awards

Related Research Articles

<span class="mw-page-title-main">Planarian</span> Flatworms of the Turbellaria class

Planarians (triclads) are free-living flatworms of the class Turbellaria, order Tricladida, which includes hundreds of species, found in freshwater, marine, and terrestrial habitats. Planarians are characterized by a three-branched intestine, including a single anterior and two posterior branches. Their body is populated by adult stem cells called neoblasts, which planarians use for regenerating missing body parts. Many species are able to regenerate any missing organ, which has made planarians a popular model in research of regeneration and stem cell biology. The genome sequences of several species are available, as are tools for molecular biology analysis.

<span class="mw-page-title-main">Cell proliferation</span> Biological process of growth and division

Cell proliferation is the process by which a cell grows and divides to produce two daughter cells. Cell proliferation leads to an exponential increase in cell number and is therefore a rapid mechanism of tissue growth. Cell proliferation requires both cell growth and cell division to occur at the same time, such that the average size of cells remains constant in the population. Cell division can occur without cell growth, producing many progressively smaller cells, while cell growth can occur without cell division to produce a single larger cell. Thus, cell proliferation is not synonymous with either cell growth or cell division, despite these terms sometimes being used interchangeably.

<span class="mw-page-title-main">Regeneration (biology)</span> Biological process of renewal, restoration, and tissue growth

Regeneration in biology is the process of renewal, restoration, and tissue growth that makes genomes, cells, organisms, and ecosystems resilient to natural fluctuations or events that cause disturbance or damage. Every species is capable of regeneration, from bacteria to humans. Regeneration can either be complete where the new tissue is the same as the lost tissue, or incomplete after which the necrotic tissue becomes fibrotic.

<span class="mw-page-title-main">Embryonic stem cell</span> Type of pluripotent blastocystic stem cell

Embryonic stem cells (ESCs) are pluripotent stem cells derived from the inner cell mass of a blastocyst, an early-stage pre-implantation embryo. Human embryos reach the blastocyst stage 4–5 days post fertilization, at which time they consist of 50–150 cells. Isolating the inner cell mass (embryoblast) using immunosurgery results in destruction of the blastocyst, a process which raises ethical issues, including whether or not embryos at the pre-implantation stage have the same moral considerations as embryos in the post-implantation stage of development.

In cellular biology, the Wnt signaling pathways are a group of signal transduction pathways which begin with proteins that pass signals into a cell through cell surface receptors. The name Wnt, pronounced "wint", is a portmanteau created from the names Wingless and Int-1. Wnt signaling pathways use either nearby cell-cell communication (paracrine) or same-cell communication (autocrine). They are highly evolutionarily conserved in animals, which means they are similar across animal species from fruit flies to humans.

<span class="mw-page-title-main">Regenerative medicine</span> Field of medicine involved in regenerating tissues

Regenerative medicine deals with the "process of replacing, engineering or regenerating human or animal cells, tissues or organs to restore or establish normal function". This field holds the promise of engineering damaged tissues and organs by stimulating the body's own repair mechanisms to functionally heal previously irreparable tissues or organs.

<span class="mw-page-title-main">Elaine Fuchs</span> American cell biologist

Elaine V. Fuchs is an American cell biologist known for her work on the biology and molecular mechanisms of mammalian skin and skin diseases, who helped lead the modernization of dermatology. Fuchs pioneered reverse genetics approaches, which assess protein function first and then assess its role in development and disease. In particular, Fuchs researches skin stem cells and their production of hair and skin. She is an investigator at the Howard Hughes Medical Institute and the Rebecca C. Lancefield Professor of Mammalian Cell Biology and Development at The Rockefeller University.

Douglas A. Melton is an American medical researcher who is the Xander University Professor at Harvard University, and was an investigator at the Howard Hughes Medical Institute until 2022. Melton serves as the co-director of the Harvard Stem Cell Institute and was the first co-chairman of the Harvard University Department of Stem Cell and Regenerative Biology. Melton is the founder of several biotech companies including Gilead Sciences, Ontogeny, iPierian, and Semma Therapeutics. Melton holds membership in the National Academy of the Sciences, the American Academy of Arts and Sciences, and is a founding member of the International Society for Stem Cell Research.

<span class="mw-page-title-main">Sean J. Morrison</span> Canadian-American cancer researcher

Sean J. Morrison is a Canadian-American stem cell biologist and cancer researcher. Morrison is the director of Children's Medical Center Research Institute at UT Southwestern (CRI), a nonprofit research institute established in 2011 as a joint venture between Children’s Health System of Texas and UT Southwestern Medical Center. With Morrison as founding director, CRI was established to perform transformative biomedical research at the interface of stem cell biology, cancer and metabolism to better understand the biological basis of disease. He is a Howard Hughes Medical Institute Investigator, has served as president of the International Society for Stem Cell Research, and is a member of the U.S. National Academy of Medicine, U.S. National Academy of Sciences and European Molecular Biology Organization.

<span class="mw-page-title-main">Cell potency</span> Ability of a cell to differentiate into other cell types

Cell potency is a cell's ability to differentiate into other cell types. The more cell types a cell can differentiate into, the greater its potency. Potency is also described as the gene activation potential within a cell, which like a continuum, begins with totipotency to designate a cell with the most differentiation potential, pluripotency, multipotency, oligopotency, and finally unipotency.

<span class="mw-page-title-main">Mesenchymal stem cell</span> Multipotent, non-hematopoietic adult stem cells present in multiple tissues

Mesenchymal stem cells (MSCs), also known as mesenchymal stromal cells or medicinal signaling cells, are multipotent stromal cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes and adipocytes.

<span class="mw-page-title-main">MYF5</span> Protein-coding gene in the species Homo sapiens

Myogenic factor 5 is a protein that in humans is encoded by the MYF5 gene. It is a protein with a key role in regulating muscle differentiation or myogenesis, specifically the development of skeletal muscle. Myf5 belongs to a family of proteins known as myogenic regulatory factors (MRFs). These basic helix loop helix transcription factors act sequentially in myogenic differentiation. MRF family members include Myf5, MyoD (Myf3), myogenin, and MRF4 (Myf6). This transcription factor is the earliest of all MRFs to be expressed in the embryo, where it is only markedly expressed for a few days. It functions during that time to commit myogenic precursor cells to become skeletal muscle. In fact, its expression in proliferating myoblasts has led to its classification as a determination factor. Furthermore, Myf5 is a master regulator of muscle development, possessing the ability to induce a muscle phenotype upon its forced expression in fibroblastic cells.

Margaret Buckingham, is a British developmental biologist working in the fields of myogenesis and cardiogenesis. She is an honorary professor at the Pasteur Institute in Paris and emeritus director in the Centre national de la recherche scientifique (CNRS). She is a member of the European Molecular Biology Organization, the Academia Europaea and the French Academy of Sciences.

Amy J. Wagers is the Forst Family Professor of Stem Cell and Regenerative Biology at Harvard University and Harvard Medical School, an investigator in islet cell and regenerative biology at the Joslin Diabetes Center, and principal faculty of the Harvard Stem Cell Institute. She is co-chair of the Department of Stem Cells and Regenerative Biology at Harvard Medical School.

Directed differentiation is a bioengineering methodology at the interface of stem cell biology, developmental biology and tissue engineering. It is essentially harnessing the potential of stem cells by constraining their differentiation in vitro toward a specific cell type or tissue of interest. Stem cells are by definition pluripotent, able to differentiate into several cell types such as neurons, cardiomyocytes, hepatocytes, etc. Efficient directed differentiation requires a detailed understanding of the lineage and cell fate decision, often provided by developmental biology.

Valerie Horsley is an American cell and developmental biologist. She currently works as an associate professor at Yale University, where she has extensively researched the growth, restoration, and maintenance of skin cells. She is a currently a member of the Yale Cancer Center and Yale Stem Cell Center. She received a Presidential Early Career Award for Scientists and Engineers in 2012 and in 2013 she was the recipient of the Rosalind Franklin Young Investigator Award.

<span class="mw-page-title-main">Tissue growth</span> Biologic term on tissues

Tissue growth is the process by which a tissue increases its size. In animals, tissue growth occurs during embryonic development, post-natal growth, and tissue regeneration. The fundamental cellular basis for tissue growth is the process of cell proliferation, which involves both cell growth and cell division occurring in parallel.

Thomas A. Rando is an American stem cell biologist and neurologist, best known for his research on basic mechanisms of stem cell biology and the biology of aging. He is the Director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and a professor of Neurology and Molecular, Cell and Developmental Biology at the University of California, Los Angeles. Prior to joining the UCLA faculty, he served as Professor of Neurology and Neurological Sciences at Stanford University School of Medicine, where he was also founding director of the Glenn Center for the Biology of Aging. His additional roles while at Stanford included co-founder and deputy director of the Stanford Center on Longevity, founding director of Stanford's Muscular Dystrophy Association Clinic, and Chief of Neurology at the VA Palo Alto Health Care System.

<span class="mw-page-title-main">Matthias Lütolf</span> Swiss biomedical engineer

Matthias Lutolf is a bio-engineer and a professor at EPFL where he leads the Laboratory of Stem Cell Bioengineering. He is specialised in biomaterials, and in combining stem cell biology and engineering to develop improved organoid models. In 2021, he became the scientific director for Roche's Institute for Translation Bioengineering in Basel.

Aging is characterized by a progressive loss of physiological integrity, leading to impaired function and increased vulnerability to death. The hallmarks of aging are the types of biochemical changes that occur in all organisms that experience biological aging and lead to a progressive loss of physiological integrity, impaired function and, eventually, death. They were first listed in a landmark paper in 2013 to conceptualize the essence of biological aging and its underlying mechanisms.

References

  1. ↑ "Laboratories & Leaders". Baxter Laboratory for Stem Cell Biology. Retrieved 2024-05-08.
  2. 1 2 Blau, H. M.; Chiu, C. P.; Webster, C. (April 1983). "Cytoplasmic activation of human nuclear genes in stable heterocaryons". Cell. 32 (4): 1171–1180. doi:10.1016/0092-8674(83)90300-8. ISSN   0092-8674. PMID   6839359.
  3. 1 2 Chiu, C. P.; Blau, H. M. (July 1984). "Reprogramming cell differentiation in the absence of DNA synthesis". Cell. 37 (3): 879–887. doi:10.1016/0092-8674(84)90423-9. ISSN   0092-8674. PMID   6744415.
  4. 1 2 Chiu, C. P.; Blau, H. M. (February 1985). "5-Azacytidine permits gene activation in a previously noninducible cell type". Cell. 40 (2): 417–424. doi:10.1016/0092-8674(85)90155-2. ISSN   0092-8674. PMID   2578323.
  5. 1 2 Blau, H. M.; Pavlath, G. K.; Hardeman, E. C.; Chiu, C. P.; Silberstein, L.; Webster, S. G.; Miller, S. C.; Webster, C. (1985-11-15). "Plasticity of the differentiated state". Science. 230 (4727): 758–766. Bibcode:1985Sci...230..758B. doi:10.1126/science.2414846. ISSN   0036-8075. PMID   2414846.
  6. 1 2 Blau, H. M.; Baltimore, D. (March 1991). "Differentiation requires continuous regulation". The Journal of Cell Biology. 112 (5): 781–783. doi:10.1083/jcb.112.5.781. ISSN   0021-9525. PMC   2288865 . PMID   1999456.
  7. ↑ Yamanaka, Shinya; Blau, Helen M. (2010-06-10). "Nuclear reprogramming to a pluripotent state by three approaches". Nature. 465 (7299): 704–712. Bibcode:2010Natur.465..704Y. doi:10.1038/nature09229. ISSN   1476-4687. PMC   2901154 . PMID   20535199.
  8. 1 2 Sacco, Alessandra; Doyonnas, Regis; Kraft, Peggy; Vitorovic, Stefan; Blau, Helen M. (2008-11-27). "Self-renewal and expansion of single transplanted muscle stem cells". Nature. 456 (7221): 502–506. Bibcode:2008Natur.456..502S. doi:10.1038/nature07384. ISSN   1476-4687. PMC   2919355 . PMID   18806774.
  9. 1 2 Gilbert, P. M.; Havenstrite, K. L.; Magnusson, K. E. G.; Sacco, A.; Leonardi, N. A.; Kraft, P.; Nguyen, N. K.; Thrun, S.; Lutolf, M. P.; Blau, H. M. (2010-08-27). "Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture". Science. 329 (5995): 1078–1081. Bibcode:2010Sci...329.1078G. doi:10.1126/science.1191035. ISSN   1095-9203. PMC   2929271 . PMID   20647425.
  10. 1 2 Cosgrove, Benjamin D.; Gilbert, Penney M.; Porpiglia, Ermelinda; Mourkioti, Foteini; Lee, Steven P.; Corbel, Stephane Y.; Llewellyn, Michael E.; Delp, Scott L.; Blau, Helen M. (March 2014). "Rejuvenation of the muscle stem cell population restores strength to injured aged muscles". Nature Medicine. 20 (3): 255–264. doi:10.1038/nm.3464. ISSN   1546-170X. PMC   3949152 . PMID   24531378.
  11. 1 2 3 Ho, Andrew T. V.; Palla, Adelaida R.; Blake, Matthew R.; Yucel, Nora D.; Wang, Yu Xin; Magnusson, Klas E. G.; Holbrook, Colin A.; Kraft, Peggy E.; Delp, Scott L.; Blau, Helen M. (2017-06-27). "Prostaglandin E2 is essential for efficacious skeletal muscle stem-cell function, augmenting regeneration and strength". Proceedings of the National Academy of Sciences of the United States of America. 114 (26): 6675–6684. Bibcode:2017PNAS..114.6675H. doi: 10.1073/pnas.1705420114 . ISSN   1091-6490. PMC   5495271 . PMID   28607093.
  12. 1 2 3 Porpiglia, Ermelinda; Mai, Thach; Kraft, Peggy; Holbrook, Colin A.; de Morree, Antoine; Gonzalez, Veronica D.; Hilgendorf, Keren I.; Frésard, Laure; Trejo, Angelica; Bhimaraju, Sriram; Jackson, Peter K.; Fantl, Wendy J.; Blau, Helen M. (2022-12-01). "Elevated CD47 is a hallmark of dysfunctional aged muscle stem cells that can be targeted to augment regeneration". Cell Stem Cell. 29 (12): 1653–1668.e8. doi:10.1016/j.stem.2022.10.009. ISSN   1875-9777. PMC   9746883 . PMID   36384141.
  13. 1 2 3 4 Palla, A. R.; Ravichandran, M.; Wang, Y. X.; Alexandrova, L.; Yang, A. V.; Kraft, P.; Holbrook, C. A.; Schürch, C. M.; Ho, A. T. V.; Blau, H. M. (2021-01-29). "Inhibition of prostaglandin-degrading enzyme 15-PGDH rejuvenates aged muscle mass and strength". Science. 371 (6528): eabc8059. doi:10.1126/science.abc8059. ISSN   1095-9203. PMC   7938328 . PMID   33303683.
  14. 1 2 3 Bakooshli, Mohsen A.; Wang, Yu Xin; Monti, Elena; Su, Shiqi; Kraft, Peggy; Nalbandian, Minas; Alexandrova, Ludmila; Wheeler, Joshua R.; Vogel, Hannes; Blau, Helen M. (2023-10-11). "Regeneration of neuromuscular synapses after acute and chronic denervation by inhibiting the gerozyme 15-prostaglandin dehydrogenase". Science Translational Medicine. 15 (717): eadg1485. doi:10.1126/scitranslmed.adg1485. ISSN   1946-6242. PMC   10763629 . PMID   37820010.
  15. ↑ Pomerantz, Jason H.; Mukherjee, Semanti; Palermo, Adam T.; Blau, Helen M. (2009-04-01). "Reprogramming to a muscle fate by fusion recapitulates differentiation". Journal of Cell Science. 122 (Pt 7): 1045–1053. doi:10.1242/jcs.041376. ISSN   0021-9533. PMC   2720934 . PMID   19295131.
  16. ↑ Blau, H. M. (1992). "Differentiation requires continuous active control". Annual Review of Biochemistry. 61: 1213–1230. doi:10.1146/annurev.bi.61.070192.010025. ISSN   0066-4154. PMID   1497309.
  17. ↑ Blau, H. M.; Dhawan, J.; Pavlath, G. K. (August 1993). "Myoblasts in pattern formation and gene therapy". Trends in Genetics. 9 (8): 269–274. doi: 10.1016/0168-9525(93)90012-7 . ISSN   0168-9525. PMID   8379006.
  18. ↑ Lutolf, Matthias P.; Doyonnas, Regis; Havenstrite, Karen; Koleckar, Kassie; Blau, Helen M. (January 2009). "Perturbation of single hematopoietic stem cell fates in artificial niches". Integrative Biology. 1 (1): 59–69. doi:10.1039/b815718a. ISSN   1757-9708. PMC   2902161 . PMID   20023792.
  19. ↑ Lutolf, Matthias P.; Gilbert, Penney M.; Blau, Helen M. (2009-11-26). "Designing materials to direct stem-cell fate". Nature. 462 (7272): 433–441. Bibcode:2009Natur.462..433L. doi:10.1038/nature08602. ISSN   1476-4687. PMC   2908011 . PMID   19940913.
  20. ↑ Sampath, Srinath C.; Sampath, Srihari C.; Ho, Andrew T. V.; Corbel, Stéphane Y.; Millstone, Joshua D.; Lamb, John; Walker, John; Kinzel, Bernd; Schmedt, Christian; Blau, Helen M. (2018-04-18). "Induction of muscle stem cell quiescence by the secreted niche factor Oncostatin M". Nature Communications. 9 (1): 1531. Bibcode:2018NatCo...9.1531S. doi:10.1038/s41467-018-03876-8. ISSN   2041-1723. PMC   5906564 . PMID   29670077.
  21. ↑ Dieleman, Joseph L.; Cao, Jackie; Chapin, Abby; Chen, Carina; Li, Zhiyin; Liu, Angela; Horst, Cody; Kaldjian, Alexander; Matyasz, Taylor; Scott, Kirstin Woody; Bui, Anthony L.; Campbell, Madeline; Duber, Herbert C.; Dunn, Abe C.; Flaxman, Abraham D. (2020-03-03). "US Health Care Spending by Payer and Health Condition, 1996-2016". JAMA. 323 (9): 863–884. doi:10.1001/jama.2020.0734. ISSN   1538-3598. PMC   7054840 . PMID   32125402.
  22. ↑ Beaudart, Charlotte; Rizzoli, René; Bruyère, Olivier; Reginster, Jean-Yves; Biver, Emmanuel (2014). "Sarcopenia: burden and challenges for public health". Archives of Public Health. 72 (1): 45. doi: 10.1186/2049-3258-72-45 . ISSN   0778-7367. PMC   4373245 . PMID   25810912.
  23. ↑ "Helen M. Blau Inventions, Patents and Patent Applications - Justia Patents Search". patents.justia.com. Retrieved 2024-05-08.
  24. ↑ "Three faculty members named National Academy of Inventors fellows". News Center. Retrieved 2024-05-08.
  25. ↑ Thomas, James A.; Hamm, Thomas E.; Perkins, Pamela L.; Raffin, Thomas A.; The Stanford University Medical Center Committee on Ethics (1988-06-16). "Animal Research at Stanford University". New England Journal of Medicine. 318 (24): 1630–1632. doi:10.1056/NEJM198806163182429. ISSN   0028-4793. PMID   3374537.
  26. ↑ Greely, H. T.; Hamm, T.; Johnson, R.; Price, C. R.; Weingarten, R.; Raffin, T. (1989-04-20). "The ethical use of human fetal tissue in medicine. Stanford University Medical Center Committee on Ethics". The New England Journal of Medicine. 320 (16): 1093–1096. doi:10.1056/NEJM198904203201624. ISSN   0028-4793. PMID   2535632.
  27. ↑ "Guidelines". International Society for Stem Cell Research. Retrieved 2024-05-08.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.